NDC 51808-201

ACD Solution Modified

Acd Solution Modified

ACD Solution Modified is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Anhydrous Citric Acid.

• Product ID: 51808-201_651af678-d1d2-4e8e-8fe0-ae6c0ba11a16
• NDC: 51808-201
• Product Type: Human Prescription Drug
• Proprietary Name: ACD Solution Modified
• Generic Name: Acd Solution Modified
• Dosage Form: Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2012-05-23
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: AnazaoHealth Corporation
• Substance Name: ANHYDROUS CITRIC ACID
• Active Ingredient Strength: 8 mg/mL
• Pharm Classes: Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 51808-201-01

10 mL in 1 VIAL (51808-201-01)

• Marketing Start Date: 2012-05-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51808-201-01 [51808020101]

ACD Solution Modified SOLUTION

• Marketing Category: Unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2012-05-23
• Inactivation Date: 2019-11-13

Drug Details

Active Ingredients

Ingredient	Strength
ANHYDROUS CITRIC ACID	8 mg/mL

OpenFDA Data

• SPL SET ID: 64a9b51b-c982-4d50-ab58-a5b9029a7602
• Manufacturer:
  • AnazaoHealth Corporation
• UNII:
  • XF417D3PSL

Pharmacological Class

• Acidifying Activity [MoA]
• Calculi Dissolution Agent [EPC]
• Anti-coagulant [EPC]
• Decreased Coagulation Factor Activity [PE]
• Calcium Chelating Activity [MoA]